ロード中...

Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer’s Disease Clinical Trial Recruitment

INTRODUCTION: The apolipoprotein E (APOE) gene is the strongest known genetic risk factor for sporadic Alzheimer’s disease (AD). APOE can be used as an enrichment strategy or inclusion criterion for AD prevention trials. Personal genomics companies market direct-to-consumer (DTC) genetic tests, incl...

詳細記述

保存先:
書誌詳細
出版年:Alzheimer Dis Assoc Disord
主要な著者: Ryan, Mary M., Cox, Chelsea G., Witbracht, Megan, Hoang, Dan, Gillen, Daniel L., Grill, Joshua D.
フォーマット: Artigo
言語:Inglês
出版事項: 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8044253/
https://ncbi.nlm.nih.gov/pubmed/33060367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0000000000000421
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!